Benzinga | Jun 10, 2021 08:39AM EDT

ProPhase Labs Announces Formation Of ProPhase Precision Medicine And ProPhase Global Healthcare Subsidiaries

ProPhase Labs, Inc. (NASDAQ:PRPH), a diversified medical science and technology company, today announced the formation of two wholly-owned subsidiaries, ProPhase Precision Medicine, Inc., which will focus on genomics testing technologies, and ProPhase Global Healthcare, Inc., which was recently formed to seek to expand the Company's SARS-CoV-2 (COVID-19) testing into other countries and to pursue additional healthcare-related initiatives.